Evidence map›Paper›PMID 28973365›Full record

ArticleGlycobiology2017

Immobilization alters heparin cleaving properties of heparinase I.

Indu Bhushan, Alhumaidi Alabbas, Balagurunathan Kuberan, Ram B Gupta, Umesh R Desai

Open access · bronzeAbstract read
In one paragraph

Article in Glycobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Indu BhushanInstitute for Structural Biology, Drug Discovery and Development.
Alhumaidi AlabbasInstitute for Structural Biology, Drug Discovery and Development.
Balagurunathan KuberanDepartment of Medicinal Chemistry, University of Utah, Salt Lake City, UT 84132, USA.
Ram B GuptaDepartment of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, VA 23284, USA.
Umesh R DesaiInstitute for Structural Biology, Drug Discovery and Development.
Virginia Commonwealth University · USPrince Sattam Bin Abdulaziz University · SAUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report here a novel observation that immobilization of heparinase I on CNBr-activated Sepharose results in heparin degradation properties that are different from heparinase I in the free solution form. Studies over a range of pHs (5-8) and temperatures (5-50°C) as well as under batch and flow conditions show that immobilized heparinase 1 displays altered pH and temperature optima, and a higher propensity for generation of longer chains (hexa- and octa-) with variable sulfation as compared to that in the free form, which is known to yield disaccharides. The immobilized enzyme retained good eliminase activity over at least five cycles of reuse. In combination, results suggest that heparinase I immobilization may offer a more productive route to longer, variably sulfated sequences.

Indexed as

Enzymes, ImmobilizedGlycosaminoglycansHeparin LyaseOligosaccharidesSepharoseEnzymes, ImmobilizedGlycosaminoglycansHeparin LyaseOligosaccharidesSepharoseglycosaminoglycansheparinaseimmobilizationoligosaccharides

Identifiers

PMID28973365
PMCPMC5881678
OpenAlexW2746955209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.